Sara Centuori

540 total citations
21 papers, 385 citations indexed

About

Sara Centuori is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Sara Centuori has authored 21 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Sara Centuori's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Sara Centuori is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Sara Centuori collaborates with scholars based in United States, France and Mexico. Sara Centuori's co-authors include Jesse D. Martinez, Charles W. Putnam, Julie E. Bauman, Darya Alizadeh, Bernard Bonnotte, Nona Janikashvili, Emmanuel Katsanis, Nicolas Larmonier, Neale T. Hanke and Claire B. Larmonier and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Sara Centuori

21 papers receiving 379 citations

Peers

Countries citing papers authored by Sara Centuori

Since Specialization

Citations

This map shows the geographic impact of Sara Centuori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Centuori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Centuori more than expected).

Fields of papers citing papers by Sara Centuori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Centuori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Centuori. The network helps show where Sara Centuori may publish in the future.

Co-authorship network of co-authors of Sara Centuori

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Centuori. A scholar is included among the top collaborators of Sara Centuori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Centuori. Sara Centuori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer 2023 ·Journal of Clinical Oncology ·Julie E. Bauman, Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, (unknown), (unknown), Conor Steuer, (unknown), Barbara Burtness, Sara Centuori, Carlos Caulı́n, Robert J. Klein, Kathylynn Saboda, (unknown), Christine H. Chung	25
2	Abstract P065: Effects of metformin on breast tissue inflammation in premenopausal women with components of metabolic syndrome 2023 ·Cancer Prevention Research ·(unknown), Sara Centuori, José Guillen-Rodriguez, Denise J. Roe, (unknown), Pavani Chalasani, H.‐H. Sherry Chow	1
3	Randomized Crossover Trial Evaluating Detoxification of Tobacco Carcinogens by Broccoli Seed and Sprout Extract in Current Smokers 2022 ·Cancers ·Julie E. Bauman, Chiu‐Hsieh Hsu, Sara Centuori, José Guillen-Rodriguez, Linda L. Garland, Emily Ho, (unknown), (unknown), (unknown), (unknown), Éva Szabó, H.‐H. Sherry Chow	10
4	Immunotherapy to prevent progression on active surveillance study (IPASS): A phase II, randomized, double-blind, controlled trial of PROSTVAC in prostate cancer patients who are candidates for active surveillance. 2022 ·Journal of Clinical Oncology ·J. Kellogg Parsons, Peter A. Pinto, Howard L. Parnes, Christian P. Pavlovich, Edward Uchio, Mike Nguyen, Hyung Lae Kim, James L. Gulley, Houssein Abdul Sater, Christina Jamieson, Chiu‐Hsieh Hsu, (unknown), Jeffrey Schlom, Renee N. Donahue, Sara Centuori, (unknown), Julie E. Bauman, H.‐H. Sherry Chow	1
5	Increased PD‐L1 Expression in Human Skin Acutely and Chronically Exposed to UV Irradiation 2021 ·Photochemistry and Photobiology ·Sally E. Dickinson, (unknown), (unknown), (unknown), Sara Centuori, Kathylynn Saboda, Valerie Calvert, Emanuel F. Petricoin, Clara Curiel‐Lewandrowski	14
6	A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density 2021 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Pavani Chalasani, Sara Centuori, Denise J. Roe, José Guillen-Rodriguez, Chuan Huang, (unknown), Cynthia A. Thomson, María I. Altbach, (unknown), (unknown), Jessica A. Martinez, Amit M. Algotar, H.‐H. Sherry Chow	12
7	Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention 2021 ·Current Treatment Options in Oncology ·Sara Centuori, Carlos Caulı́n, Julie E. Bauman	2
8	Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC). 2021 ·Journal of Clinical Oncology ·Julie E. Bauman, Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, (unknown), (unknown), Conor Steuer, (unknown), Barbara Burtness, Sara Centuori, Carlos Caulı́n, Kathylynn Saboda, (unknown), Christine H. Chung	3
9	Clinical trials optimizing investigator and self‐collection of buccal cells for RNA yield 2021 ·Laryngoscope Investigative Otolaryngology ·J.L. Geiger, (unknown), Yan Zang, Daniel P. Normolle, Hua Li, Jennifer R. Grandis, Sara Centuori, Daniel E. Johnson, Julie E. Bauman	4
10	<p>Hypoxia Suppresses High Fat Diet-Induced Steatosis And Development Of Hepatic Adenomas</p> 2019 ·PubMed ·(unknown), (unknown), (unknown), Sara Centuori, Sairam Parthasarathy, Jesse D. Martinez	2
11	Measuring DNA content in live cells by fluorescence microscopy 2018 ·Cell Division ·(unknown), Michael W. Harman, Sara Centuori, Charles W. Wolgemuth, Jesse D. Martinez	38
12	Double-negative (CD27−IgD−) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations 2018 ·Journal of Translational Medicine ·Sara Centuori, (unknown), (unknown), Charles W. Putnam, Brandon T. Larsen, Linda L. Garland, David W. Mount, Jesse D. Martinez	34
13	The induction of endoreduplication and polyploidy by elevated expression of 14-3-3γ 2017 ·Genes & Cancer ·(unknown), Sara Centuori, Michael W. Harman, Charles W. Putnam, Charles W. Wolgemuth, Jesse D. Martinez	5
14	Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Sara Centuori, (unknown), (unknown), (unknown), (unknown), Charles W. Putnam, Jesse D. Martinez	42
15	Comparative analysis of 14-3-3 isoform expression and epigenetic alterations in colorectal cancer 2015 ·BMC Cancer ·(unknown), (unknown), Sara Centuori, (unknown), Jesse D. Martinez	15
16	T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1 2015 ·BioMed Research International ·Malika Trad, (unknown), Jennifer Fraszczak, Darya Alizadeh, Claire B. Larmonier, (unknown), Sara Centuori, Sylvain Audia, Maxime Samson, Marion Ciudad, Francis Bonnefoy, Stéphanie Lemaire‐Ewing, Emmanuel Katsanis, Sylvain Perruche, Philippe Saas, Bernard Bonnotte	5
17	Differential Regulation of EGFR–MAPK Signaling by Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in Colon Cancer 2014 ·Digestive Diseases and Sciences ·Sara Centuori, Jesse D. Martinez	54
18	Abstract 3509: Overexpression of 14-3-3γ contributes to chromosomal instability in human lung cancer 2014 ·Cancer Research ·(unknown), Sara Centuori, Jesse D. Martinez	2
19	Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25−FoxP3− T cells 2012 ·Journal of Leukocyte Biology ·Sara Centuori, Malika Trad, (unknown), Darya Alizadeh, Claire B. Larmonier, Neale T. Hanke, (unknown), Nona Janikashvili, Bernard Bonnotte, Nicolas Larmonier, Emmanuel Katsanis	65
20	Th-1 Lymphocytes Induce Dendritic Cell Tumor Killing Activity by an IFN-γ–Dependent Mechanism 2011 ·The Journal of Immunology ·(unknown), Nona Janikashvili, Claire B. Larmonier, Darya Alizadeh, Neale T. Hanke, (unknown), (unknown), Sara Centuori, (unknown), Bernard Bonnotte, Emmanuel Katsanis, Nicolas Larmonier	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact